Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 37784671
Wolframin is a novel regulator of tau pathology and neurodegeneration.
Chen S, Acosta D, Li L, Liang J, Chang Y, Wang C, Fitzgerald J, Morrison C, Goulbourne CN, Nakano Y, Villegas NCH, Venkataraman L, Brown C, Serrano GE, Bell E, Wemlinger T, Wu M, Kokiko-Cochran ON, Popovich P, Flowers XE, Honig LS, Vonsattel JP, Scharre DW, Beach TG, Ma Q, Kuret J, Kõks S, Urano F, Duff KE, Fu H. Chen S, et al. Acta Neuropathol. 2022 May;143(5):547-569. doi: 10.1007/s00401-022-02417-4. Epub 2022 Apr 7. Acta Neuropathol. 2022. PMID: 35389045
Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas.
Becker AP, Becker V, McElroy J, Webb A, Han C, Guo Y, Bell EH, Fleming J, Popp I, Staszewski O, Prinz M, Otero JJ, Haque SJ, Grosu AL, Chakravarti A. Becker AP, et al. Among authors: bell eh. Cancers (Basel). 2024 Apr 16;16(8):1516. doi: 10.3390/cancers16081516. Cancers (Basel). 2024. PMID: 38672598 Free PMC article.
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways.
Singh K, Han C, Fleming JL, Becker AP, McElroy J, Cui T, Johnson B, Kumar A, Sebastian E, Showalter CA, Schrock MS, Summers MK, Becker V, Tong ZY, Meng X, Manring HR, Venere M, Bell EH, Robe PA, Grosu AL, Haque SJ, Chakravarti A. Singh K, et al. Among authors: bell eh. Sci Rep. 2023 Aug 1;13(1):12424. doi: 10.1038/s41598-023-32983-w. Sci Rep. 2023. PMID: 37528172 Free PMC article.
Correspondence comprehensive characterization of a brainstem aggregoma (light and heavy chain deposition disease).
Becker AP, Osorio DS, Bell EH, Giglio P, Fleming JL, Cottrell CE, Mardis ER, Miller KE, Schieffer KM, Kelly BJ, Makary MS, Slone W, Benson D, Leonard J, Kahwash SB, Boué DR, Chakravarti A. Becker AP, et al. Among authors: bell eh. Brain Pathol. 2023 Sep;33(5):e13154. doi: 10.1111/bpa.13154. Epub 2023 Feb 24. Brain Pathol. 2023. PMID: 36827605 Free PMC article. No abstract available.
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.
Fleming JL, Pugh SL, Fisher BJ, Lesser GJ, Macdonald DR, Bell EH, McElroy JP, Becker AP, Timmers CD, Aldape KD, Rogers CL, Doyle TJ, Werner-Wasik M, Bahary JP, Yu HM, D'Souza DP, Laack NN, Sneed PK, Kwok Y, Won M, Mehta MP, Chakravarti A. Fleming JL, et al. Among authors: bell eh. JCO Precis Oncol. 2021 Sep 1;5:PO.21.00112. doi: 10.1200/PO.21.00112. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34589661 Free PMC article. Clinical Trial.
Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813.
Fleming JL, Pugh S, Bell EH, Chang SM, McElroy J, Becker A, Timmers CD, Shih HA, Ashby L, Hunter GK, Bahary JP, Schultz CJ, Kavanagh BD, Yung WA, Robins I, Werner-Wasik M, Chakravarti A. Fleming JL, et al. Among authors: bell eh. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1399. doi: 10.1016/j.ijrobp.2020.09.021. Epub 2020 Nov 18. Int J Radiat Oncol Biol Phys. 2020. PMID: 33427658 No abstract available.
39 results